COMDOUMAB
Dead / Abandoned — Abandoned — failure to respond (as of 29 Nov 2023)
What this means for you
This application is over — abandoned 15 Aug 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90894810
- Mark type
- Word mark
- Filed
- 20 Aug 2021
- Abandoned
- 15 Aug 2023
- Attorney of record
- Robert J. Kenney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for medical purposes; hemoglobin; medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for human purposes; Drugs, namely, pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for human purposes; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia
- Class 035 — Advertising and business services: Retail store services and wholesale store services featuring medicines; Retail store services and wholesale stole services featuring pharmaceutical preparations; Retail store services and wholesale store services featuring sanitary preparations; Retail store services and wholesale store services featuring medical supplies; advertising and publicity services; publicity; organization of exhibitions and events for commercial or advertising purposes; marketing the goods and services of others by providing hyperlinks to websites of others; demonstration of goods; conducting market studies; business appraisals; business investigations; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; import-export agency services
- Class 042 — Scientific and technological services: Technological research in the field of medicines and pharmaceutical preparations; research and development of new products for others; scientific laboratory services; product quality testing; conducting technical project studies in the nature of research in the field of pharmaceutical studies; chemical research; chemistry services, namely, research in the field of chemistry; chemical analysis; biological research; bacteriological research; medical and scientific research, namely, conducting clinical trials for others; scientific research
Owner
- Akeso Pharmaceuticals, Inc., Guangzhou, Guangdong, CN
Prosecution history
- 29 Nov 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 29 Nov 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 29 Nov 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 10 May 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 10 May 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 14 Feb 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Feb 2023 — NON-FINAL ACTION E-MAILED
- 14 Feb 2023 — NON-FINAL ACTION WRITTEN
- 27 Jan 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jan 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Jan 2023 — ASSIGNED TO LIE
- 28 Nov 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Oct 2022 — ASSIGNED TO EXAMINER
- 26 May 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 May 2022 — NON-FINAL ACTION E-MAILED